For the first time, NYSCF scientists generated induced pluripotent stem (iPS) cells lines from skin samples of patients with primary progressive multiple sclerosis and further, they...
NYSCF announced that Dr. Marius Wernig, of Stanford University, is the recipient of the NYSCF – Robertson Stem Cell Prize. Dr. Wernig and his team discovered...
Neurology Today featured NYSCF – Helmsley Investigator Dr. Valentina Fossati’s latest research on multiple sclerosis in a larger story about Dr. Fossati and her personal commitment...
In conjunction with the Alzheimer’s Disease Resource Center (ADRC), NYSCF presented their latest Alzheimer’s research at the Jewish Center of the Hamptons in East Hampton. Presentations...
NYSCF welcomed the 2014 class of NYSCF – Druckenmiller Postdoctoral Fellows at a reception at the Asia Society. These seven exceptional scientists work in stem cell...
A team of scientists led by the NYSCF Research Institute’s Dr. Dieter Egli report the first ever patient-specific, diploid (i.e. with two sets of chromosomes, the...
NYSCF – Robertson Stem Cell Investigator Dr. Paola Arlotta, of Harvard University, has made an exciting breakthough and paradigm shift in the basic understanding of neuroanatomy....
In an exciting new development, the Food and Drug Administration (FDA) has approved a new stem cell-derived treatment for a phase I clinical trial in the...
Multiple Sclerosis Discovery Forum followed NYSCF — Helmsley Investigator Valentina Fossati, PhD, on her quest that is as scientific as personal. When she turned 30, Fossati was diagnosed...
At our annual Innovator's retreat, our 2010 NYSCF — Robertson Stem Cell Investigators Paul Tesar, PhD, of Case Western University, and Marius Wernig, MD, PhD, of...
Multiple sclerosis, an autoimmune disease in which immune cells attack the fatty protective layer of myelin cells, may have a potential treatment. Through stem cell techniques,...
Dr. Valentina Fossati conducts research in The New York Stem Cell Foundation Laboratory to unlock the mysteries of multiple sclerosis (MS), a disease that affects...
Four NYSCF-supported researchers published exciting new research in major scientific journals this fall. In the November 6th issue of Nature, Jae-won Shim, PhD, a NYSCF –...
11/21/11 The Multiple Sclerosis Research Center of New York (MSRCNY) and the International Cellular Medicine Society (ICMS) jointly announced today the ICMS Institutional Review Board’s (IRB)...
Susan L. Solomon to Speak on ‘State of Industry’ of Regenerative Medicine at Biotech Showcase in San Francisco NEW YORK, NY (January 9, 2012) – Susan L....
NYSCF – Robertson Investigator, Dr. Paul Tesar of Case Western Reserve University, published in Nature Methods today that they have succesfully produced the myelinating cells that...
For the second in our series of researcher interviews, we bring you some thoughts from Dr. Paul Tesar, a member of the inaugural class of NYSCF...
Reuters “CHICAGO (Reuters) – U.S. researchers have reversed multiple sclerosis symptoms in early stage patients by using bone marrow stem cell transplants to reset the immune...
The New York Stem Cell Foundation expresses its disappointment in the state of New Jersey for voting “no” on the Stem Cell Research Bond Act ballot...
